Stockscreener 앱 받기
1.96
1.81%
0.03
전일 마감가:
$1.93
열려 있는:
$1.95
하루 거래량:
2.27M
Relative Volume:
0.13
시가총액:
$248.93M
수익:
-
순이익/손실:
$-112.46M
주가수익비율:
-1.1951
EPS:
-1.64
순현금흐름:
$-99.89M
1주 성능:
-0.25%
1개월 성능:
-9.86%
6개월 성능:
+118.33%
1년 성능:
+138.18%
1일 변동 폭
$1.90
$2.02
1주일 범위
$1.90
$2.11
52주 변동 폭
$0.1311
$3.29
보 바이오파마 Stock (VOR) Company Profile
명칭
Vor Biopharma Inc
전화
617-655-6580
주소
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
VOR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
1.965 | 244.50M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.88 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.37 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
570.36 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
748.64 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
338.17 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
보 바이오파마 Stock (VOR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-30 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | 개시 | Wedbush | Outperform |
| 2022-04-27 | 개시 | Goldman | Neutral |
| 2021-12-17 | 개시 | H.C. Wainwright | Buy |
| 2021-12-03 | 개시 | Robert W. Baird | Outperform |
| 2021-12-02 | 개시 | Oppenheimer | Outperform |
| 2021-10-19 | 개시 | JMP Securities | Mkt Outperform |
| 2021-03-25 | 개시 | B. Riley Securities | Buy |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-03-03 | 개시 | Evercore ISI | Outperform |
| 2021-03-02 | 개시 | Goldman | Sell |
| 2021-03-02 | 개시 | Stifel | Buy |
모두보기
보 바이오파마 주식(VOR)의 최신 뉴스
Vor Biopharma shares rise 2.59% premarket after Connect Biopharma's Nasdaq listing. - AInvest
Quantitative breakdown of Vor Biopharma Inc. recent moveOptions Play & High Win Rate Trade Tips - Newser
What’s next for Vor Biopharma Inc. stock priceMarket Growth Report & Low Drawdown Momentum Trade Ideas - Newser
Does Vor Biopharma Inc. fit your quant trading modelWeekly Trend Summary & Advanced Swing Trade Entry Alerts - Newser
Sector ETF performance correlation with Vor Biopharma Inc.Quarterly Growth Report & Free Safe Capital Growth Stock Tips - Newser
Is Vor Biopharma Inc. stock overvalued or fairly priced2025 Major Catalysts & Weekly High Return Stock Opportunities - khodrobank.com
Custom strategy builders for tracking Vor Biopharma Inc.2025 Big Picture & Verified Entry Point Signals - Newser
Real time social sentiment graph for Vor Biopharma Inc.July 2025 Catalysts & High Accuracy Swing Trade Signals - Newser
Price momentum metrics for Vor Biopharma Inc. explained2025 Market Sentiment & Consistent Growth Equity Picks - Newser
Is Vor Biopharma Inc. stock a good pick for beginnersJuly 2025 Opening Moves & High Accuracy Buy Signal Tips - khodrobank.com
How cyclical is Vor Biopharma Inc.’s revenue streamWeekly Earnings Recap & Safe Entry Momentum Stock Tips - khodrobank.com
Vor Biopharma Inc. stock trend outlook and recovery pathMarket Weekly Review & Long-Term Safe Investment Plans - Newser
Measuring Vor Biopharma Inc.’s beta against major indicesTrade Volume Summary & Free Technical Pattern Based Buy Signals - Newser
Using data filters to optimize entry into Vor Biopharma Inc.July 2025 Drop Watch & Verified Technical Trade Signals - Newser
Is Vor Biopharma Inc. gaining market shareJuly 2025 Earnings & Weekly High Potential Alerts - khodrobank.com
Applying chart zones and confluence areas to Vor Biopharma Inc.Bond Market & Consistent Profit Trade Alerts - Newser
Building trade automation scripts for Vor Biopharma Inc.Portfolio Return Summary & Expert-Curated Trade Recommendations - Newser
Can Vor Biopharma Inc. grow without external fundingJuly 2025 Institutional & Low Risk High Reward Trade Ideas - khodrobank.com
What data driven models say about Vor Biopharma Inc.’s futurePortfolio Return Report & AI Enhanced Execution Alerts - Newser
Using flow based indicators on Vor Biopharma Inc.Dividend Hike & Safe Capital Growth Stock Tips - Newser
Trend analysis for Vor Biopharma Inc. this weekEarnings Miss & Long-Term Growth Stock Strategies - Newser
How to integrate Vor Biopharma Inc. into portfolio analysis toolsJuly 2025 Technicals & Verified Momentum Stock Watchlist - Newser
Multi factor analysis applied to Vor Biopharma Inc.July 2025 Earnings & Weekly Top Gainers Trade List - Newser
Does Vor Biopharma Inc. show high probability of reboundJuly 2025 Decliners & Weekly High Potential Stock Alerts - Newser
Risk vs reward if holding onto Vor Biopharma Inc.July 2025 Reactions & Verified Swing Trading Watchlist - Newser
What is Vor Biopharma Inc.’s book value per share2025 Big Picture & Technical Pattern Based Buy Signals - خودرو بانک
Vor Biopharma Focuses on Telitacicept Development Strategy - MSN
Can Vor Biopharma Inc. recover in the next quarterIPO Watch & Expert Curated Trade Ideas - Newser
Can Vor Biopharma Inc. lead its sector in growthJuly 2025 Momentum & Long-Term Growth Portfolio Plans - khodrobank.com
Harvard Law Graduate Adi Osovsky Joins Clinical-Stage Biotech Vor Bio as General Counsel After iTeos Success - Stock Titan
Best data tools to analyze Vor Biopharma Inc. stockWeekly Investment Summary & Fast Exit and Entry Trade Guides - Newser
Chart based analysis of Vor Biopharma Inc. trendsEarnings Overview Report & Low Drawdown Trading Techniques - Newser
Support Zone Holds Steady for Vor Biopharma Inc. After Dip getLinesFromResByArray error: size == 0 - 강소기업뉴스
Is Vor Biopharma Inc. a strong growth stock2025 Trade Ideas & Smart Money Movement Tracker - khodrobank.com
보 바이오파마 (VOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
보 바이오파마 주식 (VOR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Reprogrammed Interchange LLC | 10% Owner |
Aug 28 '25 |
Sale |
2.01 |
806,351 |
1,621,975 |
36,884,567 |
| Reprogrammed Interchange LLC | 10% Owner |
Aug 27 '25 |
Sale |
2.01 |
611,647 |
1,226,536 |
37,690,918 |
| Reprogrammed Interchange LLC | 10% Owner |
Aug 25 '25 |
Sale |
2.12 |
387,346 |
819,740 |
38,586,755 |
| Reprogrammed Interchange LLC | 10% Owner |
Aug 26 '25 |
Sale |
2.08 |
284,190 |
591,343 |
38,302,565 |
0.76%
자본화:
|
볼륨(24시간):